Migraine headache. Migraine, unspecified
Conditions
Interventions
Intervention 1: Intervention group: This group is given a fixed and routine medication (propranolol 20 to 40 mg plus sodium valproate 200 to 400 mg) along with coenzyme Q10 in the form of 100 mg capsu
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women Aged 18 to 45 Informed Consent to Participate in The Study Completeness of Patient File Information and Records Diagnosis of The Disease By a Doctor Definitive Diagnosis of Migraine
Exclusion criteria
Exclusion criteria: Suffering from chronic diseases Secondary headache or other types of primary headache except migraine Taking food supplements or medicine Pregnant and lactating women Smokers & alcoholics History of significant side effects or recent use of melatonin supplements Chronic mental illness and a history of severe depression during the last year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of headache attacks. Timepoint: day. Method of measurement: Patient statements.;Frequency of headache attacks. Timepoint: Number. Method of measurement: Patient statements.;Duration of headache. Timepoint: Clock. Method of measurement: Patient statements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Behnaz Izadpanahi
Zahedan University of Medical Sciences
Outcome results
None listed